General Info
Location: 200 Clarendon Street
Country: United States of America
Industries: pharmaceuticals, biotechnology, medical devices, diagnostics, life science tools
Investment Regions: EA
Investment Stages: late-stage
vc
EA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Bain Capital Life Sciences led or participated in a $150M Series C financing for Atsena Therapeutics on April 2, 2025. The most recent press releases on the firm’s site also show activity in July 2025 (Bristol Myers Squibb collaboration). The most recent confirmed investment involving a portfolio company (Atsena Therapeutics) occurred less than 3 months before the reference date, indicating very recent activity.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Andrew …
Managing Director
Adam …
Managing Director
Alborz …
Associate
Amir …
Principal
Benjamin …
Principal
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Bain Capital Life Sciences
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI